SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Prefilled Syringe Development and Compatibility Testing – V 2.0

Sterile Injectable Manufacturing: SOP for Prefilled Syringe Development and Compatibility Testing – V 2.0

Standard Operating Procedure for Prefilled Syringe Development and Compatibility Testing in Sterile Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/016/2025
Supersedes SOP/SIM/016/2022
Page No. Page 1 of 15
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standard procedure for the development of prefilled syringe (PFS) formulations and conduct compatibility studies to ensure product safety, container-closure integrity, and stability.

2.

Scope

This SOP applies to the formulation development team, packaging development, analytical development, and quality assurance personnel involved in PFS design, formulation filling trials, and compatibility studies within sterile injectable manufacturing.

3. Responsibilities

  • Formulation Scientist: Develops stable PFS-compatible formulations.
  • Packaging Development Officer: Selects appropriate syringe system and evaluates material compatibility.
  • Analytical Chemist: Performs extractable/leachable, stability, and physicochemical testing.
  • QA Department: Verifies compliance with regulatory and GMP guidelines.

4. Accountability

The Head of R&D is accountable for successful development and compatibility validation of prefilled syringe systems for injectable products as per regulatory and GMP requirements.

5. Procedure

5.1 Prefilled Syringe Component Selection

  1. Select syringe type (e.g., glass, cyclic olefin polymer, siliconized) based on drug product compatibility.
  2. Consider factors such as:
    • Drug adsorption to barrel material
    • Plunger stopper compatibility
    • Lubrication effects (e.g., silicone oil)
  3. Document material specifications (Annexure-1).

5.2 Formulation Design

  1. Ensure isotonicity, pH range (4.5–7.5), low viscosity, and absence of particulates.
  2. Design solution to minimize interaction with syringe components.
  3. Perform forced degradation to understand reactive sites.

5.3 Compatibility Studies

  1. Perform Extractables and Leachables (E&L) studies under ICH conditions.
  2. Analyze for:
    • Siloxanes from siliconized components
    • Heavy metals or polymers
    • Label adhesive or ink migration
  3. Record results in the Compatibility Data Log (Annexure-2).

5.4 Syringe Filling Trials

  1. Fill pilot batches using aseptic technique or terminal sterilization if applicable.
  2. Inspect for defects: cracks, silicon oil droplets, plunger movement.
  3. Check plunger glide force and hold-up volume (residual volume).

5.5 Container Closure Integrity Testing (CCIT)

  1. Test seal integrity using:
    • Vacuum Decay
    • Dye Ingress
    • Helium Leak Detection (for critical drugs)
  2. Document CCIT test results in Annexure-3.

5.6 Stability Study in Prefilled Syringes

  1. Conduct real-time and accelerated stability as per ICH Q1A guidelines.
  2. Test parameters:
    • Appearance, assay, degradation products
    • Extractables/leachables at T0, T1, T3, T6 months
    • CCIT post-exposure

5.7 Documentation and Reporting

  1. Compile the Formulation and Compatibility Report (Annexure-4).
  2. Submit development summary to QA for archiving.

6. Abbreviations

  • PFS: Prefilled Syringe
  • CCIT: Container Closure Integrity Testing
  • ICH: International Council for Harmonisation
  • E&L: Extractables and Leachables
  • QA: Quality Assurance

7. Documents

  1. Syringe Material Specification Sheet – Annexure-1
  2. Compatibility Study Data Log – Annexure-2
  3. CCIT Summary Report – Annexure-3
  4. Formulation & Compatibility Report – Annexure-4

8. References

  • ICH Q1A(R2): Stability Testing
  • ICH Q9: Quality Risk Management
  • USP <1207>: Container Closure Integrity Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Formulation Scientist QA Officer R&D Head
Department R&D Quality Assurance Sterile Injectables

11. Annexures

Annexure-1: Syringe Material Specification Sheet

Component Material Supplier Tested By
Barrel Glass Type I Gerresheimer Sunita Reddy
Plunger Bromobutyl West Pharma Rajesh Kumar

Annexure-2: Compatibility Study Data Log

Batch No. Study Condition Observation Analyst
PFS-B-001 40°C/75%RH – 1M No change Arvind Joshi

Annexure-3: CCIT Summary Report

Test Method Batch No. Result Performed By
Vacuum Decay PFS-B-001 Pass Sunita Reddy

Annexure-4: Formulation & Compatibility Report

Product Drug-X Prefilled Syringe
Batch No. PFS-DEV-001
Prepared By Rajesh Kumar
Date 10/06/2025

Revision History

Revision Date Revision No. Details Reason Approved By
05/01/2022 1.0 Initial SOP release New development procedure QA Manager
18/06/2025 2.0 Added CCIT and E&L details Regulatory compliance QA Manager
Exit mobile version